NCA
VMD icon

New Century Advisors’s Viemed Healthcare VMD Stock Holding History

New Century Advisors’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,957
Closed -$21K – 122
2021
Q4 		$21K Buy
+3,957
New +$22.1K 0.02% 100

Other funds holding VMD

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

New Century Advisors's VMD Position: Q1 2022 in Review

New Century Advisors sold out of Viemed Healthcare (VMD) in Q1 2022, closing a stake of 3,957 shares — an estimated $21K sold.

New Century Advisors first reported a position in VMD in Q4 2021 and held it in 1 quarter. The position peaked at $21K in Q4 2021. 88 funds tracked by Wall St. Rank hold VMD as of Q1 2022.

  • New Century Advisors reported no remaining Viemed Healthcare position as of Q1 2022 after selling out during the quarter.
  • New Century Advisors sold 3,957 Viemed Healthcare shares in Q1 2022, an estimated $21K.
  • New Century Advisors first reported a position in Viemed Healthcare in Q4 2021 and held it in 1 quarter.
  • New Century Advisors's Viemed Healthcare position peaked at $21K in Q4 2021.
  • 88 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2022.

Based on New Century Advisors's 13F filing for Q1 2022, filed 21 Apr 2022.